mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0008 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0009 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
0.001 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.002 |